Evidence map›Paper›PMID 40308585›Full record

ArticleFrontiers in immunology2025

Multi-omics landscape of alternative splicing in diffuse midline glioma reveals immune- and neural-driven subtypes with implications for spliceosome-targeted therapy.

Chaxian Liu, Yue Liu, Hao Lin, Chufan Zhang, Bilong Zhang, Haikun Song, Xiaomin Fan, Yi Lyu, Hui Yang, Ying Mao

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chaxian Liu *Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Yue Liu *Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Hao Lin *Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Chufan ZhangDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Bilong ZhangDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Haikun SongDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Xiaomin FanInstitute for Translational Brain Research, Shanghai Medical College, Fudan University, Shanghai, China.
Yi LyuInstitute for Translational Brain Research, Shanghai Medical College, Fudan University, Shanghai, China.
Hui YangDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Ying MaoDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: H3K27-altered diffuse midline glioma (DMG) is a highly aggressive glioma subtype, accounting for approximately 60% of pediatric high-grade gliomas, with a median survival of less than 12 months. Due to its predominant localization in the brainstem, conventional surgical resection is often unfeasible, underscoring the urgent need for alternative therapeutic strategies. While previous studies on DMG have primarily focused on regulatory mechanisms at the protein level, the role of alternative splicing in DMG remains largely unexplored. Given its potential impact on gene regulation and tumor progression, a comprehensive analysis of alternative splicing could provide novel insights into targeted or immune therapeutic strategies, complementing existing transcriptomic studies of DMG. Methods: To investigate the alternative splicing landscape of DMG, we performed transcriptome sequencing (RNA-seq) on patient-derived H3WT and H3K27-altered DMG cell lines, integrating these data with RNA-seq and single-cell transcriptomic (scRNA-seq) datasets from published sources. This comprehensive approach enabled us to delineate the alternative splicing landscape of H3K27-altered DMG and validate its distinct features at the cellular level. Results: Our multi-omics analysis revealed significant transcriptional alterations in H3K27-altered DMG compared to H3WT DMG, particularly in pathways related to neuro-regulation, metabolism, and immunity. Further in-depth analysis identified extensive alternative splicing changes in H3K27-altered DMG, predominantly associated with RNA modifications and key alterations in extracellular matrix and nucleotide metabolism. Integrating these findings, we characterized five RNA-associated proteins that enabled a binary classification of DMG into neural and immune subtypes, with each subtype exhibiting distinct prognostic and transcriptomic features. Notably, we identified Discussion: Our findings indicate that H3K27-altered DMG exhibits significant alternative splicing alterations, which play crucial roles in tumorigenesis and progression. Additionally, our study identified an RNA-binding protein-based classification of DMG and characterized

Indexed as

Alternative SplicingBrain NeoplasmsGliomaSpliceosomesCell Line, TumorGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMultiomicsTranscriptomealternative splicingDMGH3K27-alteredimmunemetabolismmulti-omicsposttranscriptional modificationstumorigenesis

Identifiers

PMID40308585
PMCPMC12040961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.